Estimated antiretroviral therapy coverage among people living with HIV in AMR
AMR: Estimated antiretroviral therapy coverage among people living with HIV was 71.0% in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in AMR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in AMR is 71.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 2.9% on the previous year and up 31.5% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in AMR peaked at 71.0% in 2025 and was at its lowest, 16.0%, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in AMR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 16.0% | — |
| 2001 | 19.0% | +18.8% |
| 2002 | 20.0% | +5.3% |
| 2003 | 23.0% | +15.0% |
| 2004 | 25.0% | +8.7% |
| 2005 | 27.0% | +8.0% |
| 2006 | 29.0% | +7.4% |
| 2007 | 31.0% | +6.9% |
| 2008 | 33.0% | +6.5% |
| 2009 | 36.0% | +9.1% |
| 2010 | 39.0% | +8.3% |
| 2011 | 42.0% | +7.7% |
| 2012 | 45.0% | +7.1% |
| 2013 | 47.0% | +4.4% |
| 2014 | 50.0% | +6.4% |
| 2015 | 54.0% | +8.0% |
| 2016 | 56.0% | +3.7% |
| 2017 | 58.0% | +3.6% |
| 2018 | 60.0% | +3.4% |
| 2019 | 63.0% | +5.0% |
| 2020 | 65.0% | +3.2% |
| 2021 | 66.0% | +1.5% |
| 2022 | 67.0% | +1.5% |
| 2023 | 68.0% | +1.5% |
| 2024 | 69.0% | +1.5% |
| 2025 | 71.0% | +2.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.9% | 16.0% | 36.0% | 10 |
| 2010s | 51.4% | 39.0% | 63.0% | 10 |
| 2020s | 67.7% | 65.0% | 71.0% | 6 |
Countries ranked near AMR
More health data for AMR
- Mortality rate among children ages 5 to 9 years 1.08 (2024)
- Population with primary reliance on polluting fuels and technologies 42.21 (2023)
- Population with primary reliance on fuels and technologies for 37.18 (2023)
- Proportion of population with primary reliance on fuels and 33.6% (2023)
- Prevalence of diabetes, crude 14.59 (2022)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 92.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 88.0% (2025)
- New HIV infections 0.18 (2025)
- BCG immunization coverage among 1-year-olds (%) 88.0% (2025)
- Mean HDL cholesterol, crude 1.2 (2018)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in AMR?
- Estimated antiretroviral therapy coverage among people living with hiv in AMR was 71.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in AMR?
- The highest recorded value was 71.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in AMR?
- The lowest recorded value was 16.0% in 2000.
- How does AMR rank for estimated antiretroviral therapy coverage among people living with hiv?
- AMR ranks 4th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in AMR?
- Over the last ten years it is up 31.5%. The long-run trend across the full record is rising.
- Where does this AMR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).